Trifluoroacetyl Tripeptide-2 is a next-generation biomimetic signal peptide. In scientific literature, it is linked to modulating a specific biological marker: progerin.
Progerin is a truncated protein derived from a variant of the lamin A gene, a structural protein of the cell nucleus. Its presence in skin cells naturally increases with age. This accumulation is associated in scientific literature with progressive disruption of nuclear structure and alteration of essential cellular functions, contributing to visible signs of aging.
Trifluoroacetyl Tripeptide-2 is associated, according to available data, with limiting progerin accumulation in skin cells. In vitro data link this modulation to preserving extracellular matrix quality and better visible tissue cohesion.
In vivo studies reported by the supplier associate this peptide, at 2%, with visible improvement in skin firmness and suppleness of about 20% in 28 days, as well as visible reduction of age-related signs, notably wrinkles, apparent sagging, and jawline firmness appearance.
Its approach is documented as targeting a mechanism linked in scientific literature to visible signs of aging, for progressive action on skin appearance.
In summary, a next-generation biomimetic peptide documented for its association with progerin modulation and visible improvement in skin firmness and suppleness.
